SJS Investment Consulting Inc. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
SJS Investment Consulting Inc. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$123
-38.8%
4
-20.0%
0.00%
Q2 2023$201
-18.0%
5
-16.7%
0.00%
Q1 2023$245
+26.9%
6
+20.0%
0.00%
Q4 2022$1935
+25.0%
0.00%
Q3 2022$0
-100.0%
4
-97.5%
0.00%
-100.0%
Q1 2022$12,000
+20.0%
163
+0.6%
0.00%
+33.3%
Q4 2021$10,0001620.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders